Clinical Trial Update: Focal Impulse and Rotor Modulation Ablation Trial for Treatment of Paroxysmal Atrial Fibrillation (FIRMAT-PAF) [NA]

View source ↗

Summary

The FIRMAT-PAF focal impulse and rotor modulation ablation trial for paroxysmal atrial fibrillation has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Atrial Fibrillation

Snippet

Sponsor: Indiana University | Conditions: Paroxysmal Atrial Fibrillation | NA | Status: TERMINATED